A major breakthrough in the fight against COVID-19 came with the discovery that a low-cost steroid, dexamethasone, can significantly reduce death rates in critically ill patients. This finding marks the first time a drug has been shown to lower mortality among COVID-19 sufferers, providing hope and relief across the globe.
According to a report published by Science, dexamethasone reduced deaths by one-third in ventilated patients and by one-fifth in those receiving oxygen. The drug is inexpensive, widely available, and already used for other conditions, making it a practical solution during the pandemic.
The results highlight the importance of re-evaluating existing medications for new uses. With dexamethasone now part of treatment protocols in many countries, health experts emphasize the value of continued research in discovering effective, accessible treatments.
For more on this significant medical development, read the full article here: A cheap steroid is the first drug shown to reduce death in COVID-19 patients
Courtesy of Science.